We also found significant upregulation of hepatic expression of SREBF1, SREBF2, HNF4A, and KLF13 in NAFL and NASH compared to the control group (adjusted p value < 0.05, Figures 5B–5F; Data S2). Here, KLF13 is linked to metabolic dysfunction-associated steatohepatitis.